Please wait while we open this resource.
K
Clinical reviews
SGLT2 Inhibitors: A New Therapeutical Strategy to Improve Clinical Outcomes in Patients with Chronic Kidney Diseases
Department of Medical and Surgical Sciences, Magna Græcia University of Catanzaro; Division of Cardiology, Università degli Studi di Napoli 'Federico II'
PDF14 pages1.5 MB
The document discusses the growing evidence from randomized controlled trials that demonstrate the benefits of SGLT2 inhibitors in improving outcomes for patients with chronic kidney disease. It highlights the expanded indications for these medications, including glycemic control, reduction in cardiovascular disease, heart failure, and both diabetic and non-diabetic kidney disease. The findings from significant trials such as DAPA-CKD and EMPA-Kidney are emphasized, showcasing the effectiveness of SGLT2 inhibitors in reducing the progression of kidney disease and cardiovascular mortality.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
CARDIOVASCULAR COMPLICATIONS IN CHRONIC KIDNEY DISEASE: A REVIEW FROM THE EUROPEAN RENAL AND CARDIOVASCULAR MEDICINE WORKING GROUP OF THE EUROPEAN RENAL ASSOCIATION
Same clinical topic · Nephrology
THE ASSOCIATION BETWEEN DUAL RAAS INHIBITION AND RISK OF ACUTE KIDNEY INJURY AND HYPERKALEMIA IN PATIENTS WITH DIABETIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Same clinical topic · Nephrology
OBESITY IN CKD: CORE CURRICULUM 2026
Same clinical topic · Nephrology
OBESITY IN CKD: CORE CURRICULUM 2026
Same clinical topic · Nephrology
ACUTE GLOMERULONEPHRITIS
Same clinical topic · Nephrology
DISEASE MODIFICATION IN LUPUS NEPHRITIS: TOWARDS A PATHOPHYSIOLOGY-BASED TREATMENT PARADIGM
Same clinical topic · Nephrology
Effects of correction rate for severe hyponatremia in the intensive care unit on patient outcomes
Same clinical topic · Nephrology
CURRENT UNDERSTANDING OF SODIUM-GLUCOSE TRANSPORTER 2 INHIBITORS IN CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME
Same clinical topic · Nephrology
A COMPREHENSIVE REVIEW OF ACUTE CARDIO-RENAL SYNDROME: NEED FOR NOVEL BIOMARKERS
Same clinical topic · Nephrology